NLS Pharmaceutics AG: NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds
Management to Discuss Pipeline Goals and Development Strategies across four Preclinical and 2 Clinical Programs across Multiple Central Nervous System (CNS) DisordersNLS to Webcast its R&D Day Event Tuesday
Source: finanznachrichten.de